PubMed Health⌕ Search

Biomedical subjects

J K Cuddeback

Publications and source records attributed to J K Cuddeback.

9 recordsLinked to original sources

Impact of race on the treatment for peripheral arterial occlusive disease.

PURPOSE: The purpose of this study was to determine the impact of race on the treatment of peripheral artery occlusive disease (PAOD) and to examine the role of access to care and disease distribution on the observed racial disparity. METHODS: The study was performed as a retrospective analysis of hospital discharge abstracts from 1992 to 1995 in 202 non-federal, acute-care hospitals in the state of Florida. The subjects were patients older than 44 years of age who underwent major lower extremity amputation or revascularization (bypass grafting or angioplasty) for PAOD. The main outcome measures were incidence of intervention, incidence per demographic group, multivariate predictors of amputation versus revascularization, multivariate predictors of amputation versus revascularization among those patients with access to sophisticated care (hospital with arteriographic capabilities), and multivariate predictors of surgical bypass graft type (aortoiliac vs infrainguinal). RESULTS: A total of 51,819 procedures (9.1 per 10,000 population) were performed for PAOD during the study period and included 15,579 major lower extremity amputations (30.1%) and 36,240 revascularizations (69.9%). Although the incidence of a procedure for PAOD was comparable between African Americans and whites (9.0 vs 9.6 per 10, 000 demographic group), the incidence of amputation (5.0 vs 2.5 per 10,000 demographic group) was higher and the incidence of revascularization (4.0 vs 7.1 per 10,000 demographic group) was lower among African Americans. Furthermore, multivariate analysis results showed that African Americans (odds ratio, 3.79; 95% confidence interval [CI], 3.34 to 4.30) were significantly more likely than whites to undergo amputation as opposed to revascularization. The secondary multivariate analyses results revealed that African Americans (odds ratio, 2.29; 95% CI, 1.58 to 3. 33) were more likely to undergo amputation among those patients (n = 9193) who underwent arteriography during the procedural admission and to undergo infrainguinal bypass grafting (odds ratio, 2.00; 95% CI, 1.48 to 2.71) among those patients (n = 27,796) who underwent surgical bypass grafting. CONCLUSION: There is a marked racial disparity in the treatment of patients with PAOD that may be caused in part by differences in the severity of disease or disease distribution.

Age Factors↗

Readmission for group B streptococci or Escherichia coli infection among full-term, singleton, vaginally delivered neonates after early discharge from Florida hospitals for births from 1992 through 1994.

BACKGROUND: In Florida during the period 1992 through 1994, there was a major drop in the length of stay for full-term, singleton, vaginally delivered newborn babies in the hospital. A major concern on the part of clinicians has been the potential of an increased risk of sepsis (manifesting itself after discharge) associated with earlier newborn discharge from the hospital. We used the Florida hospital discharge dataset to study the frequency of readmission with sepsis after early newborn discharge to home. METHODS: Using the Florida Agency for Health-Care Administration Acute Care Hospital Discharge Dataset, we used a multivariate, probabilistic matching algorithm to merge newborn discharge records for births from 1992 through 1994 with readmission discharge records (including hospital-to-hospital transfers and multiple readmissions) during the first 28 days of life. We used the resulting merged dataset to study bacterial infection diagnoses on newborn and readmission records and to examine relationships between readmission diagnoses and timing of newborn discharge among the 364,528 full-term, singleton, vaginally delivered babies (FTSVDBs) without congenital anomalies from 1992 through 1994 in Florida acute-care hospitals. RESULTS: Overall, 86.3% of all FTSVDBs born in Florida acute-care hospitals were discharged between day of life (DOL) 0 (born and discharged the same day) and DOL 2 (discharged two calendar days after birth). The group B streptococci (GBS) infection code was found on the newborn discharge records of 9.2 per 10,000 FTSVDBs over the 3-year period, 5.9% of which involved hospital-to-hospital transfer of the baby. Escherichia coli infection codes were found on the records of 3.4 per 10,000 FTSVDBs over the 3-year period, 2.3% of which involved hospital-to-hospital transfer of the baby. Of those FTSVDBs discharged to home without infection codes during DOL 1 to 2, 0.8 per 10,000 were readmitted within 7 days (inclusive) with GBS infection, and 2.0 per 10,000 with E. coli infection. When the data for readmitted babies were pooled for 1992 through 1994, the odds ratio for probability of readmission comparing discharges on DOL 1 to DOL 2 for GBS was 2.27 (95% confidence interval, 1.83 to 2.70), and for E. coli 2.16 (95% confidence interval, 1.46 to 2.85). Over this 3-year period, for babies discharged on DOL 1, there was a 115% increase in the rate of readmission for GBS from 1992 through 1994 (p < 0.01) and a 36.5% increase in the rate of readmission for E. coli (p < 0.05). However, among FTSVDBs discharged on DOL 2, the rate of readmission for both GBS and E. coli did not change during the period 1992 through 1994. There were no deaths among FTSVDBs as either newborns, transfers, or readmissions within 7 days of discharge, with either GBS or E. coli infection codes on their discharge record. CONCLUSION: From 1992 through 1994, the increased number of babies discharged early in Florida was temporally associated with an increased rate of readmission during the week after discharge for both GBS and E. coli infection among babies discharged on the calendar day after birth. With an increase in both the number of babies exposed to the risks of early discharge, and an increased rate of these serious infections during the week after discharge from the hospital, the number of these babies grew to exceed, by several fold, the number of babies with inborn errors of metabolism picked up by state screening programs.

Age Factors↗

Effect of the Asymptomatic Carotid Atherosclerosis Study on carotid endarterectomy in Florida.

BACKGROUND AND PURPOSE: The value of carotid endarterectomy (CEA) has been defined by several recent multicenter trials. The clinical effect of these trials remains undetermined since the Asymptomatic Carotid Atherosclerosis Study (ACAS) Clinical Advisory (dated September 28, 1994). METHODS: Patients undergoing CEA (ICD-9-CM 38.12) in nonfederal Florida hospitals were identified from the discharge database. Data were analyzed by federal fiscal year (FY, October 1 through September 30), comparing the years following the Advisory (FY95-FY96) to the preceding 3 years (FY92-FY94). RESULTS: There was a 68.3% increase in the number of CEAs during FY95-FY96 (mean FY92-FY94, 7,343; mean FY95-FY96, 12,356). This exceeded increases in total hospital discharges (4.5%), surgical discharges (2.2%), and the state's population (4.7%). The increase in CEAs spanned all patient demographic groups (gender, race, and age), although the magnitude was not consistent (range, 57.8% increase for 55 to 64 age group; 92.9% increase for > 84 age group). Concomitantly, there was a significant decrease in mortality (1.2% versus 0.8%), cardiac complication rate (ICD-9-CM 997.1, 4.1% versus 3.0%) and percentage of patients discharged > 7 days postoperatively (8.9% versus 4.9%). Mean length of stay declined 28% (5.8 versus 4.1 days), and mean adjusted charges declined 7% ($19,456 versus $18,055). Although the average case was less costly, the increased volume resulted in an estimated $56 million increase in annual hospital payments. CONCLUSIONS: The dramatic increase in the number of CEAs performed in the state of Florida after release of the ACAS Clinical Advisory suggests a causal relationship and mandates further cost-effectiveness analyses.

Adult↗

Integration of health care information systems.

Information is at the core of an effective response to virtually all of the new demands that health care institutions will face in the 1990s. New information that is differently organized, more timely, and more conveniently available will facilitate new interactions within the institution. The consistent theme of the new systems requirements introduced by CQI is tighter connection to the processes of patient care and integration of systems and data as those processes cross traditional organizational boundaries. Even the billing requirements are pushing in the same direction. Ironically, the dinosaurs descended from billing systems do not even perform very well as billing systems today, because payers want more clinical detail, in addition to information at very specific points during the patient-care process. This new management model changes our view of our systems. Instead of systems designed to create an after-the-fact record of patient care, we need to think in terms of systems that are part of the patient-care process. This is essential for the continuous monitoring and--when the process gets out of control--rapid intervention that are an intrinsic part of the process in the CQI model. Of course, these systems also produce a complete record as a by-product, but that is not their primary objective. These demands will test the capacities of many of our existing systems and will require the replacement of others. Like all complex processes, however, systems development is performed one step at a time. Each step is taken within the context of an overall goal but also presents an opportunity for learning. CQI is a new management model, and the system requirements are far from clear. Hence, we are likely to need a little continuous improvement in the systems, too.

Accounting↗